Get started
CVS HEALTH CORPORATIONCVS HEALTH CORPORATIONCVS HEALTH CORPORATION

CVS HEALTH CORPORATION

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

CVS trade ideas

Long Play on $CVSHi All, I've entered a long position on $CVS. I believe that COVID-19 vaccine distributions throughout Q1 and Q2 will aid $CVS with additional revenue, giving them the ability to further scale and efficiently grow at a rapid pace. They are currently sitting at ~ $97B market cap- I expect an additional $40B - $50B of revenue to be added to their income statement ending 2021, accounting for just Q1 and Q2 alone. 328 million people strictly in America need to be vaccinated, COVID will be treated just like the flu- in terms of yearly shots to the doctor or health provider. I'm entering a long position until my $91.64 limit order hits. GLTA! I am not a financial advisor, my posts are my opinions and mine only. Please do your own due diligence as well before investing.
NYSE:CVSLong
by ClargyInvesting
Long play with short opportunitiesWe could see some shorting opportunities with the quadruple witching coming up, it seems all of nasdaq is bearish. If price continues to drop, our next support will be the $61.70 level. If our $61.70 support level holds we could see a little back and forth between those key levels as price tries to retest. We could even see price break $61.70 and test the next support level, but looking at the bigger picture, we're looking forward to a long bullish movement following this short bearish move. Not only is CVS the USA's top pharmacy and playing a huge part in the administration of the COVID-19 vaccine coming very soon, but CVS stock price just recently broke out of a 5 year downtrend that started in August of 2015 when price was at $113/share. That 5 year trendline is also a possible point of interest as price could try to retest it if our support level is broken.
NYSE:CVSLong
by Potticus
2
CVS bullish trajectory for possible weekend gap jumpCVS fundamentals are impeccable: P/B 1.48, P/E 12, Div/Yield 2.68%, Q3 revenue $67B, 2020 earnings guidance $7.35-7.45 per share. CVS is the largest pharmacy in the US. 70% percent of the US population lives within three minutes of a CVS store. CVS fair value is $92 updated on November 20 by Morningstar. I entered CVS$73-75strangle12/11 contracts at 3:30pm on 12/4 to have insurance on the low end *just in case. $75call Delta: .44, Theta: .09, $73put Delta: .30, Theta: .07. From the look of it, CVS checks all the boxes: technically, fundamentally & newsworthy are all bullish for CVS. (Bloomberg) CVS Health will administer Eli Lilly's Covid-19 treatment in patients homes and in long-term care facilities through a program with the U.S. government’s Operation Warp Speed, the pharmacy chain said. Lilly’s monoclonal antibody therapy, bamlanivimab, has been found to keep patients in the early stages of Covid-19 from developing more severe disease that requires hospitalization. Do your own due diligence, your risk is 100% your responsibility. You win some or you learn some. Consider being charitable with some of your profit to help humankind. Small incremental steps work : If you double a penny for a month it = $5,368,709. Good luck and happy trading friends... *3x lucky 7s of trading* 7pt Trading compass: Price action, entry/exit Volume average/direction Trend, patterns, momentum Newsworthy current events Revenue Earnings Balance sheet 7 Common mistakes: +5% portfolio trades, risk management Beware of analysts motives Emotions & Opinions FOMO : bad timing Lack of planning & discipline Forgetting restraint Obdurate repetitive errors 7 Important tools: Trading View app!, Brokerage UI Accurate indicators & settings Wide screen monitor/s Trading log (pencil & graph paper) Big organized desk Reading books, playing chess Sorted watch-list Checkout my indicators: Fibonacci VIP - volume Fibonacci MA7 - price pi RSI - trend momentum www.tradingview.com
NYSE:CVSLong
by Options360
14
CVS HEALTH CORPORATION Chart DailyHey people, CVS HEALTH CORPORATION is in bullish momentum with a large hammer candle and abnormal acht volume. In the TIMEFRAME M1 we see a marubozu with a large volume of purchases issued, it is in the middle of a range test. Great possibility of breaking out the price and at the same time arranging it to arrive in the one above and go to the next higher. With several high notably (on TIMEFRAME H4) upstream and an excess (on TIMEFRAME H1) Before we start breaking the intermediate median of ANDREWS PICHTFORK. And if the buyers are still in the process, reach the second high verifacation (on the TIMEFRAME H4) with an excess on the TIMEFRAME H1. Little force to arrive at half of the intermediate median of the fork ANDREWS PICHTFORK Please LIKE & FOLLOW, thank you!
NYSE:CVSShort
by stephanelibatd